| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2024 | Feb 9, 2024 | Adverum Biotechnologies, Inc. | Director | Buy | 95.0 | +100,000 | 2999.40% | ✗ | $135K |
| Nov 15, 2021 | Nov 17, 2021 | Adverum Biotechnologies, Inc. | Director | Sell | 22.5 | -50,000 | -93.75% | ✗ | $109K |
| Feb 14, 2020 | Feb 14, 2020 | Adverum Biotechnologies, Inc. | Director | Buy | 95.0 | +10,000 | 50.00% | ✗ | $137.5K |
| May 6, 2019 | May 6, 2019 | Adverum Biotechnologies, Inc. | Director | Buy | 95.0 | +20,000 | 100.00% | ✗ | $134.2K |
| Feb 1, 2012 | Feb 3, 2012 | Verastem, Inc. | Other | Buy | 95.0 | +100,000 | 5.17% | ✗ | $1M |